{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:08:09Z","timestamp":1783098489115,"version":"3.54.6"},"reference-count":125,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T00:00:00Z","timestamp":1560470400000},"content-version":"vor","delay-in-days":225,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.5604\/01.3001.0012.7191","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T06:29:00Z","timestamp":1541399340000},"page":"908-919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Immunometabolic Effect of Cholesterol in Hepatitis C Infection: Implications in Clinical Management and Antiviral Therapy"],"prefix":"10.1016","volume":"17","author":[{"given":"Karina","family":"Gonz\u00e1lez-Aldaco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Torres-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ojeda-Granados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Jos\u00e9-\u00c1brego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora A.","family":"Fierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.5604\/01.3001.0012.7191_bib0005","unstructured":"WHO. Hepatitis C. 2018. Available from: http:\/\/wwwwhoint\/ news-room\/fact-sheets\/detail\/hepatitis-c"},{"key":"10.5604\/01.3001.0012.7191_bib0010","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.5604\/01.3001.0012.7191_bib0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/icb.2014.12","article-title":"Immunometabolism: the interface of immune and metabolic responses in disease","volume":"92","author":"Schertzer","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"10.5604\/01.3001.0012.7191_bib0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri3169","article-title":"Living in the liver: hepatic infections","volume":"12","author":"Protzer","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.5604\/01.3001.0012.7191_bib0025","first-page":"892","article-title":"Hepatitis C virus life cycle and lipid metabolism","volume":"3","author":"Popescu","year":"2014","journal-title":"Biology (Basel)"},{"key":"10.5604\/01.3001.0012.7191_bib0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tem.2009.07.005","article-title":"Hepatitis C virus hijacks host lipid metabolism","volume":"21","author":"Syed","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.5604\/01.3001.0012.7191_bib0035","first-page":"24","article-title":"Steatosis and hepatitis C","volume":"4","author":"Modaresi Esfeh","year":"2016","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.5604\/01.3001.0012.7191_bib0040","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s10620-015-3760-3","article-title":"Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review","volume":"60","author":"Dyal","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.5604\/01.3001.0012.7191_bib0045","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.cmi.2016.07.019","article-title":"Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma","volume":"22","author":"Vescovo","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.5604\/01.3001.0012.7191_bib0050","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jmb.2013.10.032","article-title":"Activation and evasion of antiviral innate immunity by hepatitis C virus","volume":"426","author":"Horner","year":"2014","journal-title":"J Mol Biol"},{"key":"10.5604\/01.3001.0012.7191_bib0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00281-012-0332-x","article-title":"Innate immune responses in hepatitis C virus infection","volume":"35","author":"Li","year":"2013","journal-title":"Semin Immunopathol"},{"key":"10.5604\/01.3001.0012.7191_bib0060","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3181\/00379727-200-43424","article-title":"Tumor necrosis factor, interleukin, and interferon induced changes in lipid metabolism as part of host defense","volume":"200","author":"Grunfeld","year":"1992","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1 Suppl.","key":"10.5604\/01.3001.0012.7191_bib0065","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.7191_bib0070","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ncpgasthep0961","article-title":"Mechanisms of Disease: HCV-induced liver injury","volume":"4","author":"Mengshol","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.7191_bib0075","doi-asserted-by":"crossref","unstructured":"Cacoub P, Si Ahmed SN, Ferfar Y, Pol S, Thabut D, Hezode C, Alric L, et al. Long-Term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis. Clin Gastroenterol Hepatol 2018.","DOI":"10.1016\/j.cgh.2018.05.021"},{"key":"10.5604\/01.3001.0012.7191_bib0080","doi-asserted-by":"crossref","unstructured":"Rivero-Juarez A, Brieva T, Frias M, Rivero A. Pharmacodynamic and pharmacokinetic evaluation of the combination of daclatasvir\/sofosbuvir\/ribavirin in the treatment of chronic hepatitis C. Expert Opin Drug Metab Toxicol 2018: 1-10.","DOI":"10.1080\/17425255.2018.1506765"},{"key":"10.5604\/01.3001.0012.7191_bib0085","unstructured":"Flamm S, Reddy KR, Zadeikis N, Hassanein T, Bacon BR, Maieron A, Zeuzem S, et al. Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV Infection. Clin Gastroenterol Hepatol 2018."},{"key":"10.5604\/01.3001.0012.7191_bib0090","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2174\/1389557517666170913111930","article-title":"Recent Advancement of Direct-acting Antiviral Agents (DAAs) in Hepatitis C Therapy","volume":"18","author":"Das","year":"2018","journal-title":"Mini Rev Med Chem"},{"key":"10.5604\/01.3001.0012.7191_bib0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/cid\/civ220","article-title":"The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus","volume":"61","author":"Rein","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.5604\/01.3001.0012.7191_bib0100","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.3748\/wjg.v22.i22.5137","article-title":"Need of righteous attitudes towards eradication of hepatitis C virus infection in Latin America","volume":"22","author":"Panduro","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"Suppl. 1","key":"10.5604\/01.3001.0012.7191_bib0105","first-page":"S37","article-title":"Epidemiology of viral hepatitis in Mexico","volume":"53","author":"Panduro","year":"2011","journal-title":"Salud Publica Mex"},{"key":"10.5604\/01.3001.0012.7191_bib0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virusres.2010.03.009","article-title":"Molecular epidemiology of hepatitis C virus genotypes in west Mexico","volume":"151","author":"Panduro","year":"2010","journal-title":"Virus Res"},{"key":"10.5604\/01.3001.0012.7191_bib0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3727\/105221617X15100607143377","article-title":"Analysis of Naturally Occurring Resistance-Associated Variants to NS3\/4A Protein Inhibitors, NS5A Protein Inhibitors, and NS5B Polymerase Inhibitors in Patients With Chronic Hepatitis C","volume":"18","author":"Sun","year":"2018","journal-title":"Gene Expr"},{"key":"10.5604\/01.3001.0012.7191_bib0120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/apt.13263","article-title":"The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3","volume":"42","author":"Holmes","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.5604\/01.3001.0012.7191_bib0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6769-9-2","article-title":"Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus","volume":"9","author":"Pezacki","year":"2009","journal-title":"BMC Chem Biol"},{"key":"10.5604\/01.3001.0012.7191_bib0130","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response to hepatitis C virus infection","volume":"99","author":"Su","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.5604\/01.3001.0012.7191_bib0135","series-title":"Liver pathophysiology: therapies & antioxidants","first-page":"129","article-title":"The immune system and viral hepatitis","author":"Fierro","year":"2017"},{"key":"10.5604\/01.3001.0012.7191_bib0140","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nchembio.1940","article-title":"MicroRNAs regulate the immunometabolic response to viral infection in the liver","volume":"11","author":"Singaravelu","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.5604\/01.3001.0012.7191_bib0145","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.3748\/wjg.v20.i13.3443","article-title":"Immunologic, metabolic and genetic factors in hepatitis C virus infection","volume":"20","author":"Fierro","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.5604\/01.3001.0012.7191_bib0150","doi-asserted-by":"crossref","unstructured":"Suzuki T. Morphogenesis of Infectious Hepatitis C Virus Particles. Frontiers in Microbiology 2012; 3.","DOI":"10.3389\/fmicb.2012.00038"},{"key":"10.5604\/01.3001.0012.7191_bib0155","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1439-0396.2007.00752.x","article-title":"Liver lipid metabolism","volume":"92","author":"Nguyen","year":"2008","journal-title":"J Anim Physiol Anim Nutr (Berl)"},{"key":"10.5604\/01.3001.0012.7191_bib0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.5604\/01.3001.0012.7191_bib0165","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1128\/JVI.02727-13","article-title":"Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation","volume":"88","author":"Syed","year":"2014","journal-title":"J Virol"},{"key":"10.5604\/01.3001.0012.7191_bib0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1874467209666160112123603","article-title":"Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense","volume":"10","author":"Gabor","year":"2017","journal-title":"Curr Mol Pharmacol"},{"key":"10.5604\/01.3001.0012.7191_bib0175","doi-asserted-by":"crossref","unstructured":"Syed GH, Khan M, Yang S, Siddiqui A. Hepatitis C Virus Lipoviroparticles Assemble in the Endoplasmic Reticulum (ER) and Bud off from the ER to the Golgi Compartment in COPII Vesicles. J Virol 2017; 91.","DOI":"10.1128\/JVI.00499-17"},{"key":"10.5604\/01.3001.0012.7191_bib0180","doi-asserted-by":"crossref","first-page":"12020","DOI":"10.1128\/JVI.01569-08","article-title":"Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies","volume":"82","author":"Grove","year":"2008","journal-title":"J Virol"},{"key":"10.5604\/01.3001.0012.7191_bib0185","doi-asserted-by":"crossref","first-page":"21808","DOI":"10.1038\/srep21808","article-title":"CD36 is a co-receptor for hepatitis C virus E1 protein attachment","volume":"6","author":"Cheng","year":"2016","journal-title":"Scientific reports"},{"key":"10.5604\/01.3001.0012.7191_bib0190","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2222\/jsv.65.269","article-title":"Roles of lipoprotein and apolipoprotein in HCV infection","volume":"65","author":"Fukuhara","year":"2015","journal-title":"Uirusu"},{"key":"10.5604\/01.3001.0012.7191_bib0195","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/v5051292","article-title":"Hepatitis C virus, cholesterol and lipoproteins\u2014impact for the viral life cycle and pathogenesis of liver disease","volume":"5","author":"Felmlee","year":"2013","journal-title":"Viruses"},{"key":"10.5604\/01.3001.0012.7191_bib0200","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/JVI.01818-10","article-title":"Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection","volume":"85","author":"Tong","year":"2011","journal-title":"J Virol"},{"key":"10.5604\/01.3001.0012.7191_bib0205","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3390\/v6020535","article-title":"CD81 and hepatitis C virus (HCV) infection","volume":"6","author":"Feneant","year":"2014","journal-title":"Viruses"},{"key":"10.5604\/01.3001.0012.7191_bib0210","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1074\/jbc.M115.694059","article-title":"The Hepatitis C Virus-induced NLRP3 Inflammasome Activates the Sterol Regulatory Element-binding Protein (SREBP) and Regulates Lipid Metabolism","volume":"291","author":"McRae","year":"2016","journal-title":"J Biol Chem"},{"key":"10.5604\/01.3001.0012.7191_bib0215","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1073\/pnas.0700760104","article-title":"Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins","volume":"104","author":"Huang","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.5604\/01.3001.0012.7191_bib0220","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J Clin Invest"},{"key":"10.5604\/01.3001.0012.7191_bib0225","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1742-4658.2008.06806.x","article-title":"SREBPs: physiology and pathophysiology of the SREBP family","volume":"276","author":"Shimano","year":"2009","journal-title":"FEBS J"},{"key":"10.5604\/01.3001.0012.7191_bib0230","doi-asserted-by":"crossref","first-page":"E2288","DOI":"10.1210\/jc.2012-2152","article-title":"High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet","volume":"97","author":"Silbernagel","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.5604\/01.3001.0012.7191_bib0235","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1038\/srep04549","article-title":"Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes","volume":"4","author":"Lyn","year":"2014","journal-title":"Sci Rep"},{"key":"10.5604\/01.3001.0012.7191_bib0240","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1128\/JVI.06001-11","article-title":"Proline-serine-threonine phosphatase-interacting protein 2 (PSTPIP2), a host membrane-deforming protein, is critical for membranous web formation in hepatitis C virus replication","volume":"86","author":"Chao","year":"2012","journal-title":"J Virol"},{"key":"10.5604\/01.3001.0012.7191_bib0245","doi-asserted-by":"crossref","first-page":"e1003056","DOI":"10.1371\/journal.ppat.1003056","article-title":"Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication","volume":"8","author":"Romero-Brey","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.5604\/01.3001.0012.7191_bib0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0009-8981(97)06532-7","article-title":"Blood lipids of patients with chronic hepatitis: differences related to viral etiology","volume":"261","author":"Fabris","year":"1997","journal-title":"Clin Chim Acta"},{"key":"10.5604\/01.3001.0012.7191_bib0255","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1046\/j.1440-1746.2002.02813.x","article-title":"Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection","volume":"17","author":"Hui","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.7191_bib0260","first-page":"1632","article-title":"Nutrient sensing and metabolic stress pathways in innate immunity","volume":"15","author":"Tsalikis","year":"2013","journal-title":"Cell Microbiol"},{"key":"10.5604\/01.3001.0012.7191_bib0265","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1128\/JVI.00587-15","article-title":"Identification of Cholesterol 25-Hydroxylase as a Novel Host Restriction Factor and a Part of the Primary Innate Immune Responses against Hepatitis C Virus Infection","volume":"89","author":"Xiang","year":"2015","journal-title":"J Virol"},{"key":"10.5604\/01.3001.0012.7191_bib0270","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1590\/0074-02760140377","article-title":"Spontaneous hepatitis C viral clearance and hepatitis C chronic infection are associated with distinct cytokine profiles in Mexican patients","volume":"110","author":"Fierro","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.5604\/01.3001.0012.7191_bib0275","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMcibr1412016","article-title":"Cholesterol metabolism and immunity","volume":"371","author":"Simon","year":"2014","journal-title":"N Engl J Med"},{"key":"10.5604\/01.3001.0012.7191_bib0280","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.antiviral.2014.01.004","article-title":"Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection","volume":"104","author":"Ogawa","year":"2014","journal-title":"Antiviral Res"},{"key":"10.5604\/01.3001.0012.7191_bib0285","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.5604\/01.3001.0012.7191_bib0290","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/JVI.80.2.866-874.2006","article-title":"Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and inter-leukin-6","volume":"80","author":"Machida","year":"2006","journal-title":"J Virol"},{"key":"10.5604\/01.3001.0012.7191_bib0295","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.5604\/01.3001.0012.7191_bib0300","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.apsb.2014.06.010","article-title":"Recent advances in the anti-HCV mechanisms of interferon","volume":"4","author":"Huang","year":"2014","journal-title":"Acta Pharm Sin B"},{"key":"10.5604\/01.3001.0012.7191_bib0305","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chom.2007.09.003","article-title":"Cholesterol manipulation by West Nile virus perturbs the cellular immune response","volume":"2","author":"Mackenzie","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.5604\/01.3001.0012.7191_bib0310","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1089\/aid.2015.0170","article-title":"Interferon-Free Treatment of Hepatitis C Virus in HIV\/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration","volume":"32","author":"Townsend","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.5604\/01.3001.0012.7191_bib0315","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jhep.2012.02.017","article-title":"Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: evidence for an association with interferon sensitivity","volume":"57","author":"Sheridan","year":"2012","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.7191_bib0320","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/hep.26263","article-title":"Plasma interferon-gammainducible protein-10 (IP-10) levels during acute hepatitis C virus infection","volume":"57","author":"Grebely","year":"2013","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7191_bib0325","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.virol.2009.08.037","article-title":"Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor","volume":"394","author":"Owen","year":"2009","journal-title":"Virology"},{"key":"10.5604\/01.3001.0012.7191_bib0330","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/hep.26190","article-title":"Characterization of the inhibition of hepatitis C virus entry by in vitro-generated and patient-derived oxidized low-density lipoprotein","volume":"57","author":"Westhaus","year":"2013","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7191_bib0335","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.21139","article-title":"Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells","volume":"43","author":"von Hahn","year":"2006","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7191_bib0340","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.clinre.2010.11.001","article-title":"Oxidized low-density lipoprotein is associated with viral load and disease activity in patients with chronic hepatitis C","volume":"35","author":"Nakhjavani","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.5604\/01.3001.0012.7191_bib0345","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jcmgh.2015.03.002","article-title":"Oxidized Low-Density Lipoprotein Is a Novel Predictor of Interferon Responsiveness in Chronic Hepatitis C Infection","volume":"1","author":"Solbach","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.7191_bib0350","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jss.2011.06.033","article-title":"Toll-like receptor 4 mediates oxidized LDL-in-duced macrophage differentiation to foam cells","volume":"171","author":"Howell","year":"2011","journal-title":"J Surg Res"},{"key":"10.5604\/01.3001.0012.7191_bib0355","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1388-1981(00)00142-6","article-title":"Oxysterol biosynthetic enzymes","volume":"1529","author":"Russell","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.5604\/01.3001.0012.7191_bib0360","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1189\/jlb.0610318","article-title":"Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons","volume":"88","author":"Park","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.5604\/01.3001.0012.7191_bib0365","doi-asserted-by":"crossref","first-page":"34316","DOI":"10.1074\/jbc.273.51.34316","article-title":"cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism","volume":"273","author":"Lund","year":"1998","journal-title":"J Biol Chem"},{"key":"10.5604\/01.3001.0012.7191_bib0370","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","article-title":"An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha","volume":"383","author":"Janowski","year":"1996","journal-title":"Nature"},{"key":"10.5604\/01.3001.0012.7191_bib0375","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1073\/pnas.0700899104","article-title":"Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig","volume":"104","author":"Radhakrishnan","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.5604\/01.3001.0012.7191_bib0380","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.1038\/srep07242","article-title":"Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms","volume":"4","author":"Chen","year":"2014","journal-title":"Sci Rep"},{"key":"10.5604\/01.3001.0012.7191_bib0385","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1477-2574.2010.00207.x","article-title":"Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma","volume":"12","author":"Wu","year":"2010","journal-title":"HPB (Oxford)"},{"key":"10.5604\/01.3001.0012.7191_bib0390","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/hep.23796","article-title":"Associations between serum lipids and hepatitis C antiviral treatment efficacy","volume":"52","author":"Ramcharran","year":"2010","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7191_bib0395","doi-asserted-by":"crossref","first-page":"e0163644","DOI":"10.1371\/journal.pone.0163644","article-title":"Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment","volume":"11","author":"Hashimoto","year":"2016","journal-title":"PLoS One"},{"key":"10.5604\/01.3001.0012.7191_bib0400","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1440-1746.2007.04911.x","article-title":"Baseline cholesterol is associated with the response to antiviral therapy in chronic hepatitis C","volume":"23","author":"Economou","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.7191_bib0405","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4254\/wjh.v7.i12.1617","article-title":"Predictive factors associated with hepatitis C antiviral therapy response","volume":"7","author":"Cavalcante","year":"2015","journal-title":"World J Hepatol"},{"key":"10.5604\/01.3001.0012.7191_bib0410","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/cid\/ciw289","article-title":"Statin Utilization and Recommendations Among HIV- and HCV-infected Veterans: A Cohort Study","volume":"63","author":"Clement","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.5604\/01.3001.0012.7191_bib0415","doi-asserted-by":"crossref","first-page":"33G","DOI":"10.1016\/0002-9149(87)90589-3","article-title":"Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia","volume":"60","author":"Illingworth","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.5604\/01.3001.0012.7191_bib0420","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.21232","article-title":"Different anti-HCV profiles of statins and their potential for combination therapy with interferon","volume":"44","author":"Ikeda","year":"2006","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7191_bib0425","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.antiviral.2016.02.006","article-title":"Statins can exert dual, concentration dependent effects on HCV entry in vitro","volume":"128","author":"Blanchet","year":"2016","journal-title":"Antiviral Res"},{"key":"10.5604\/01.3001.0012.7191_bib0430","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"10.5604\/01.3001.0012.7191_bib0435","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/jhep.2003.50103","article-title":"Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response","volume":"37","author":"Sugimoto","year":"2003","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7191_bib0440","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/hep.28901","article-title":"The association between race\/ethnicity and the effectiveness of direct antiviral agents for hepatitis C virus infection","volume":"65","author":"Su","year":"2017","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7191_bib0445","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5604\/16652681.1231582","article-title":"High Prevalence of ITPA Alleles Associated with Ribavirin-Induced Hemolytic Anemia Among Mexican Population","volume":"16","author":"Gonzalez-Aldaco","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.5604\/01.3001.0012.7191_bib0450","doi-asserted-by":"crossref","first-page":"807","DOI":"10.12998\/wjcc.v3.i9.807","article-title":"Role of genetic polymorphisms in hepatitis C virus chronic infection","volume":"3","author":"Coppola","year":"2015","journal-title":"World J Clin Cases"},{"key":"10.5604\/01.3001.0012.7191_bib0455","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.3748\/wjg.v21.i27.8227","article-title":"Genomic medicine in gastroenterology: A new approach or a new specialty","volume":"21","author":"Roman","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.5604\/01.3001.0012.7191_bib0460","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"10.5604\/01.3001.0012.7191_bib0465","doi-asserted-by":"crossref","first-page":"17830","DOI":"10.3748\/wjg.v20.i47.17830","article-title":"Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response","volume":"20","author":"O\u2019Connor","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.5604\/01.3001.0012.7191_bib0470","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.it.2011.07.002","article-title":"Interferon-lambda and therapy for chronic hepatitis C virus infection","volume":"32","author":"Donnelly","year":"2011","journal-title":"Trends Immunol"},{"key":"10.5604\/01.3001.0012.7191_bib0475","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.5604\/01.3001.0012.7191_bib0480","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.5604\/01.3001.0012.7191_bib0485","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.5604\/01.3001.0012.7191_bib0490","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s40064-015-1137-x","article-title":"IL28B genotype predicts response to chronic hepatitis C triple therapy with telaprevir or boceprevir in treatment naive and treatment-experienced patients other than prior partial- and null-responders","volume":"4","author":"Calisti","year":"2015","journal-title":"Springerplus"},{"key":"10.5604\/01.3001.0012.7191_bib0495","doi-asserted-by":"crossref","first-page":"e0146258","DOI":"10.1371\/journal.pone.0146258","article-title":"Association with Spontaneous Hepatitis C Viral Clearance and Genetic Differentiation of IL28B\/IFNL4 Haplotypes in Populations from Mexico","volume":"11","author":"Gonzalez-Aldaco","year":"2016","journal-title":"PLoS One"},{"key":"10.5604\/01.3001.0012.7191_bib0500","doi-asserted-by":"crossref","first-page":"17030","DOI":"10.1038\/srep17030","article-title":"Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk","volume":"5","author":"Lee","year":"2015","journal-title":"Sci Rep"},{"key":"10.5604\/01.3001.0012.7191_bib0505","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/gene.2015.38","article-title":"Polymorphisms in EGFR and IL28B are associated with spontaneous clearance in an HCV-infected Iranian population","volume":"16","author":"Carapito","year":"2015","journal-title":"Genes Immun"},{"key":"10.5604\/01.3001.0012.7191_bib0510","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/hep.23592","article-title":"Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection","volume":"51","author":"Li","year":"2010","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7191_bib0515","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.gastro.2011.09.039","article-title":"Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection","volume":"142","author":"Beinhardt","year":"2012","journal-title":"Gastroenterology"},{"key":"10.5604\/01.3001.0012.7191_bib0520","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/iub.1314","article-title":"Apolipoprotein E isoforms and lipoprotein metabolism","volume":"66","author":"Phillips","year":"2014","journal-title":"IUBMB life"},{"key":"10.5604\/01.3001.0012.7191_bib0525","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/hep.23278","article-title":"Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles","volume":"51","author":"Benga","year":"2010","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7191_bib0530","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1074\/jbc.M110.175018","article-title":"Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome","volume":"286","author":"Merz","year":"2011","journal-title":"J Biol Chem"},{"key":"10.5604\/01.3001.0012.7191_bib0535","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: far more than a lipid transport protein","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.5604\/01.3001.0012.7191_bib0540","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.3748\/wjg.v21.i12.3449","article-title":"Genome-based nutrition: An intervention strategy for the prevention and treatment of obesity and nonalcoholic steatohepatitis","volume":"21","author":"Roman","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.5604\/01.3001.0012.7191_bib0545","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/gut.2005.079905","article-title":"Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection","volume":"55","author":"Price","year":"2006","journal-title":"Gut"},{"key":"10.5604\/01.3001.0012.7191_bib0550","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/jhep.2002.34745","article-title":"Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus","volume":"36","author":"Wozniak","year":"2002","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7191_bib0555","doi-asserted-by":"crossref","first-page":"e60729","DOI":"10.1371\/journal.pone.0060729","article-title":"Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia","volume":"8","author":"Lye","year":"2013","journal-title":"PLoS One"},{"key":"10.5604\/01.3001.0012.7191_bib0560","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s004390000299","article-title":"Association of the low-density lipoprotein receptor gene with obesity in Native American populations","volume":"106","author":"Mattevi","year":"2000","journal-title":"Hum Genet"},{"key":"10.5604\/01.3001.0012.7191_bib0565","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/gene.2013.56","article-title":"Association of low-density lipoprotein receptor genotypes with hepatitis C viral load","volume":"15","author":"Caruz","year":"2014","journal-title":"Genes Immun"},{"key":"10.5604\/01.3001.0012.7191_bib0570","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/QAD.0b013e328348a7ac","article-title":"Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV\/hepatitis C virus-coinfected patients","volume":"25","author":"Pineda","year":"2011","journal-title":"AIDS"},{"key":"10.5604\/01.3001.0012.7191_bib0575","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.ATV.12.9.1053","article-title":"The effect of interferon on the metabolism of LDLs","volume":"12","author":"Schectman","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.5604\/01.3001.0012.7191_bib0580","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.25501","article-title":"Role of low-density lipoprotein receptor in the hepatitis C virus life cycle","volume":"55","author":"Albecka","year":"2012","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.7191_bib0585","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbrc.2004.04.019","article-title":"Anti-HCV activities of selective polyunsaturated fatty acids","volume":"318","author":"Leu","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.5604\/01.3001.0012.7191_bib0590","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.redox.2012.12.001","article-title":"Oxysterols in the pathogenesis of major chronic diseases","volume":"1","author":"Poli","year":"2013","journal-title":"Redox biology"},{"key":"10.5604\/01.3001.0012.7191_bib0595","doi-asserted-by":"crossref","first-page":"e112346","DOI":"10.1371\/journal.pone.0112346","article-title":"Normocaloric low cholesterol diet modulates Th17\/Treg balance in patients with chronic hepatitis C virus infection","volume":"9","author":"Maggio","year":"2014","journal-title":"PLoS One"},{"key":"10.5604\/01.3001.0012.7191_bib0600","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/nu5041218","article-title":"Dyslipidemia in obesity: mechanisms and potential targets","volume":"5","author":"Klop","year":"2013","journal-title":"Nutrients"},{"key":"10.5604\/01.3001.0012.7191_bib0605","doi-asserted-by":"crossref","unstructured":"Ojeda-Granados C, Panduro A, Gonzalez-Aldaco K, Sepulveda-Villegas M, Rivera-Iniguez I, Roman S. Tailoring Nutritional Advice for Mexicans Based on Prevalence Profiles of Diet-Related Adaptive Gene Polymorphisms. J Pers Med 2017; 7.","DOI":"10.3390\/jpm7040016"},{"key":"10.5604\/01.3001.0012.7191_bib0610","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.hjr.0000085247.65733.4f","article-title":"Blood cholesterol level and prevalence of hypercholesterolaemia in developing countries: a review of populationbased studies carried out from 1979 to 2002","volume":"10","author":"Fuentes","year":"2003","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.5604\/01.3001.0012.7191_bib0615","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1073\/pnas.0409834102","article-title":"Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids","volume":"102","author":"Kapadia","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.5604\/01.3001.0012.7191_bib0620","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/AAC.01426-06","article-title":"Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture","volume":"51","author":"Yano","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.5604\/01.3001.0012.7191_bib0625","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3892\/etm.2015.2923","article-title":"Gallic acid decreases hepatitis C virus expression through its antioxidant capacity","volume":"11","author":"Govea-Salas","year":"2016","journal-title":"Exp Ther Med"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119310531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119310531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:39:31Z","timestamp":1761647971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119310531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":125,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1665268119310531"],"URL":"https:\/\/doi.org\/10.5604\/01.3001.0012.7191","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunometabolic Effect of Cholesterol in Hepatitis C Infection: Implications in Clinical Management and Antiviral Therapy","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.5604\/01.3001.0012.7191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}